Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
Injectable B12 comes in 2 forms: Short-acting B12 (Multine B12, Prolaject B12, Prolavax)- these are shortacting products and we would expect supplementation to last 3-4 weeks
Most logged side effects Side effects are logged separately from overall experience
This seems logical but creates mechanical forces that literally tear peptide bonds apart
The peptide loses its biological activity, and you are injecting expensive, inert liquid
Direccin C/ Torras i Pujalt 1, Planta 0 Clnica Sagrada Familia, consultorio n